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Abstract
Dengue fever is caused by four distinct serotypes of the dengue virus (DENV1-4), and is estimated to affect over 500
million people every year. Presently, there are no vaccines or antiviral treatments for this disease. Among the
possible targets to fight dengue fever is the viral NS3 protease (NS3PRO), which is in part responsible for viral
processing and replication. It is now widely recognized that virtual screening campaigns should consider the flexibility
of target protein by using multiple active conformational states. The flexibility of the DENV NS3PRO could explain the
relatively low success of previous virtual screening studies. In this first work, we explore the DENV NS3PRO
conformational states obtained from molecular dynamics (MD) simulations to take into account protease flexibility
during the virtual screening/docking process. To do so, we built a full NS3PRO model by multiple template homology
modeling. The model comprised the NS2B cofactor (essential to the NS3PRO activation), a glycine flexible link and the
proteolytic domain. MD simulations had the purpose to sample, as closely as possible, the ligand binding site
conformational landscape prior to inhibitor binding. The obtained conformational MD sample was clustered into four
families that, together with principal component analysis of the trajectory, demonstrated protein flexibility. These
results allowed the description of multiple binding modes for the Bz-Nle-Lys–Arg–Arg-H inhibitor, as verified by
binding plots and pair interaction analysis. This study allowed us to tackle protein flexibility in our virtual screening
campaign against the dengue virus NS3 protease.
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Introduction
Dengue fever (DF) is an infectious disease caused by four
distinct serotypes of Dengue virus (DENV1-4) transmitted by
Aedes spp. Milder manifestations of the disease may include
fever, rash, headaches, joint and muscle pain, fatigue and
vomiting. Re-infection by different serotypes, however, may
cause much more significant clinical conditions, like Dengue
Hemorrhagic Fever (DHF) and Dengue Shock Syndrome
(DSS) [1,2] which can cause death.
DF is estimated to affect over 500 million people every year
[3] and has recently been ranked as the most common cause
of febrile illness in travelers, surpassing malaria and
gastrointestinal infections [4]. Together with the ongoing
expansion of mosquito habitats [5] either due to the recent
climate changes and to the urbanization of developing
countries [6], this fact has drawn the attention of sanitary and
health centers around the globe. Two autochthonous cases in
Europe [7] and recent outbreaks in southern USA [8] have
shown that dengue is no longer exclusively a problem for
tropical developing countries. Despite its high incidence,
severity and economic burden, there are currently no antiviral
treatments nor vaccines for DF. The development of an
efficient anti-DF vaccine faces the challenge to provide
protection for all four serotypes at once [9], otherwise it may
render immunized individuals more susceptible to DHF [10].
Regarding the design of antiviral drugs, viral proteases are
often proposed as potential therapeutic targets due to their
essential task of processing viral polyproteins into their
functional unities [11]. Concerning Dengue virus (DENV) and
its close relative West Nile virus (WNV), this role is assigned to
the multi-domain nonstructural protein 3 (NS 3). NS3 is
composed by a protease (NS3PRO) and a helicase (NS3HEL)
domain, with the former being responsible for processing the
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polyprotein in specific sites (Figure 1, adapted from Umareddy
et al, 2007 [12]). The NS3PRO domain (EC 3.4.21.91) belongs to
the S7 family of serine proteases, and needs a cofactor, the
hydrophilic loop from NS2B (NS2BCF) in the case of DENV and
WNV, to become fully active [13,14].
This protease has already been recognized as a valuable
target for the design of new antiviral inhibitors against Dengue
virus [15,16], and, therefore, designing potent inhibitors against
DENV NS3PRO is an active research line in the fight against DF
[17–22]. The use of computational drug-design approaches
would be useful here to improve the discovery of putative hits
and to help obtain new leads [23–31]. However, previous
virtual screening campaigns have fallen short in the
identification of new inhibitors, since none was able to find
small organic compounds in the submicromolar inhibitory
range. It is now widely accepted that protein flexibility is an
important factor to be taken into account to ensure the success
of virtual screening campaigns [32]. The flexibility of DENV
NS3 protease is evidenced in current crystallographic
structures by the lack of atomic coordinates for many residues,
the difficulty in resolving an inhibitor-enzyme structure, the
variable positioning of the cofactor in respect to the protease,
and those of several loops [33–36]. This scenario could explain
the relatively low success of previous virtual screening
attempts against this target. In fact, the flexibility of DENV
NS2B/NS3 protease has already been proposed, but not
proved, to explain the poor results of current drug design
campaigns [21].
To address this issue, we performed molecular dynamics
(MD) simulations towards an ensemble docking campaign.
Ensemble docking is now widely recognized as an efficient
strategy for incorporating protein flexibility in virtual screening
campaigns [37–39], especially when the ensembles are
extracted from molecular dynamics simulations [40,41]. MD
simulations of DENV NS2B/NS3PRO described in the present
work intended to sample as closely as possible the ligand
binding region landscape prior to inhibitor binding. The
obtained conformational MD sample was therefore clustered
into families diverging at least 4.5 Å apart. Thus, a limited
protein conformational set, shown to contain structures
sufficiently different at their binding sites (Figure S1), was
chosen to be employed in a subsequent ensemble docking
simulation using focused chemical libraries.
Materials and Methods
Homology Modeling
We obtained most of our results before the availability of the
3D structure of the Dengue virus 3 NS2B/NS3PRO in complex
with its inhibitors [36]. However, as all of the accessible
crystallographic structures, including the novel ones, presented
missing residues, we needed to model their related segments.
In addition to that, we considered three main factors during the
construction of our 3D model. Firstly, it had to relate to the full-
length sequence of the expression construct we have (DENV 1
NS2B-Gly[4]-Ser–Gly[4]-NS3PRO). Secondly, it had to represent
the catalytically active “closed” conformation. Lastly, it needed
to be able to take into account the possible influence of N- and
C-terminus domains in the NS3 protease active site
conformational changes and/or accessibility. This led us to
build a 3D model that included the hydrophilic NS2B cofactor
region, a glycine flexible link, and the NS3 proteolytic domain in
complex with the NDL inhibitor.
To obtain this DENV NS2BCF-Gly-NS3PRO model with as
much structural information as possible, we performed an
alignment among all Dengue virus and West Nile virus
protease 3D structures available in the protein database (PDB)
at the time (Table 1). This allowed us to check the
completeness of the PDB structures compared to the
sequences deposited by the same authors. From this analysis,
we were able to gather information to build three different
models of our system: Two preliminary models based either
Figure 1.  Predicted membrane topology of the Dengue virus polyprotein and its cleavage sites.  The polyprotein is
composed of three structural subunits: capsid (C), precursor of membrane protein (PrM) and envelope (E), as well as seven
nonstructural (NS) subunits: NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5. The NS3 is a multifunctional protein composed of a
helicase domain (NS3HEL, see detailed box) and a protease (NS3PRO, also observable in the detailed box) domain, which in turn
needs the hydrophilic loop of NS2B (NS2BCF, marked in green) as a cofactor to be fully active. Red arrows indicate sites processed
by the viral NS2B/NS3 protease. Based on Figure 1 from Umareddy et al., 2007 [12], for illustrative purposes only.
doi: 10.1371/journal.pone.0072402.g001
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solely on the WNV or solely on the DENV PDB structures and
a third one mixing data from both DENV and WNV.
For each model, we prepared the PDB templates by
removing unused chains, ligands, water and ions. The cleaned
structures were aligned using the Discovery Studio Visualizer
3.1 (Accelrys, Inc) based on the sequence alignment of their
conserved residues. Prior to submission to the homology
software MODELLER [42], the sequence alignment obtained
previously was edited to ensure certain features would be
found in the resulting model, i.e., the N-terminus region
(including NS2BCF) from WNV structures and C-terminus from
DENV structures in the final model. For each set of templates
(WNV only, DENV only or WNV/DENV), five homology models
were generated, each with three loop refinements, giving us 45
models. The three lowest energy models (based on each set of
templates) were chosen and verified by PROCHECK [43] to
ensure their structural quality. We next visually compared these
models and retained the one with features from both WNV and
DENV structures, as it contained less disordered coils and
loops.
Finally, we transferred the atomic coordinates of the NS2B
cofactor and those of the NDL inhibitor (Bz-Nle-Lys–Arg–Arg-
H) from the 2FP7 PDB template into the final NS3PRO model as
obtained above. After arranging the cofactor in place, we built
the glycine linker with the homology module of the INSIGHT II
package (Accelrys Inc). The inhibitor was deliberately left
covalently unbound to simulate conformational changes in the
active site prior the formation of the protease/substrate
intermediate. Using the AutoPSF Generation Plugin provided
with VMD [44], missing hydrogens were added according to
their predicted protonation state at pH 7.0 and histidine
residues were assigned to their δ-protonated state.
Molecular Dynamics Simulations
The final model of the complex between the NDL ligand and
the NS2BCF-Gly-NS3PRO target obtained above was submitted
to MD simulations. The complex was firstly solvated with TIP3P
Table 1. Crystallographic structures used as templates in
the homology modeling process and their construct data
information.
Virus PDB id Structural information Ref.
DENV2 2FOM NS2BCF-Gly-NS3PRO [33]
DENV4 2VBC NS2B18-Gly-NS3FULLa [34]
DENV4 2WHX NS2B18-Gly-NS3FULLa [52]
DENV1 3L6P NS2BCF-Gly-NS3PROΔ10b [35]
WNV 2FP7 NS2BCF-Gly-NS3PRO + NDL [33]
WNV 2IJO NS2BCF-Gly-NS3PRO + BPTI [63]
WNV 3E90 NS2BCF-Gly-NS3PRO + NKK [69]
a. Instead of using the full hydrophilic loop from NS2B, a short sequence of 18
residues was used, only to provide solubility to the expressed complex.
b. The construct has a 10 residues deletion in the N-terminus of NS3PRO, in order to
facilitate crystallization.
NDL: Bz-Nle-Lys–Arg–Arg-H; BPTI: bovine pancreatic trypsin inhibitor; NKK:
Naph-Lys-Lys-Arg-H
explicit water molecules in a box with at least 15 Å apart from
any point in the protein, ending up with a box of 80 x 100 x 85
Å. Eight Na+ ions were added to ensure electrostatic neutrality.
Missing parameters for the ligand were added using the
CHARMM22 force field [45]. The NAMD software [46] was
used to simulate the dynamic behavior of the complex using
the parm.prm parameter file from CHARMM22 in periodic
boundary conditions. Long-range electrostatics was evaluated
using the particle-mesh Ewald approach [47]. Simulations were
carried out in the NPT ensemble using Langevin dynamics and
piston to fix temperatures (300 K) and pressure (1 atm).
Hydrogen-heavy atom bonds were constrained to their
equilibrium values with the SHAKE algorithm [48].
The system was first energy minimized (6400 conjugate
gradient steps) and then equilibrated (500 ps) before recording
the trajectories. All MD trajectory frames were recorded at 1 ps
intervals, for a total of 30 ns simulation.
Clustering
Once the MD simulations were complete, all frames were
aligned by taking into account only heavy atoms in the core
region of the NS3 protease alone (residue range from 20 to
168). This was done in order to focus the protein
conformational analysis on the binding site region only. The
RMSDs were calculated by using the appropriate VMD plugin
and the corresponding data were exported as an ASCII matrix
by the VMD Multiplot module. For clustering, a previously
developed in-house Tcl script was used with a cutoff of 4.5 Å.
This script builds a 2D RMSD matrix for identifying
conformational families within a given RMSD range.
Pocket detection and volume analysis
Pockets were detected using METAPOCKET [49], an
algorithm using several reliable pocket detection tools to
combine their results and improve sensibility. Changes in
pocket volume and surface (pocket descriptors) were
monitored with MD Pocket [50], a software capable of
analyzing topological changes in cavities during MD
simulations.
Analysis software
All molecular representations as well as several other
analyses (such as distances between catalytic residues
through the trajectory and secondary structure maintenance
over time, for example) were performed by VMD. All graphics
(RMSD, pair interactions, mobility plots, pocket volume
evolution, etc) were plotted using GraphPad Prism 5
(GraphPad Software, Inc). Two-dimensional binding plots from
docking results were generated with Discovery Studio
Visualizer 3.1 (Accelrys, Inc).
Results
Building the 3D model
PDB Templates Sequence alignment.  To build a
homology model based on the available homologous PDB
structures, we first performed a manual sequence alignment
Dengue Virus NS3PRO Active Site Flexibility
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analysis of these templates (Figure 2). This alignment shows
highly conserved residues between the DENV and WNV
NS3PRO proteins, with an overall identity of 40.6% (64.2%
similarity). One block of 5 residues, numbered 59 to 63, seems
to vary according to the DENV serotypes. A lack of structural
information at C- and N-terminal regions was found, probably
due to their high flexibility, and hence little information from
those residues could be utilized for molecular modeling.
NS3PRO N-terminus data were more likely to be found in West
Nile virus structures (Figure 2, blue box), while those of C-
terminus were better provided by full (with both protease and
helicase domains) NS3 Dengue virus structures (Figure 2, red
box).
Templates structural alignment.  Regarding the PDB
structures, while much has been said about different
conformations related to distinct serotypes [35] and about the
influence of ligands and co-factors [33], the protein core
structure is well conserved even when compared between
DENV and WNV (Figure 3A). The RMSD values for each
template main chain atoms compared to the reference protein
2FOM are given in table 2, showing that active site residues
position is similar among them, irrespectively of whether the
cofactor was in the open or closed conformation.
The situation is different for the C-terminal turn (Figure 3A,
residues 151 to 167, marked in shades of red, bottom left
corner) that adopted several spatial conformations among
Figure 2.  Dengue and West Nile virus NS2BCF-Gly-NS3PRO multiple sequence alignment extracted from the protein
databank files.  This alignment allowed us to verify the completeness of each deposed structure, as well as to fill structural gaps,
direct N- (blue box) and C-terminus (red box) regions and the cofactor itself. Green triangles indicate the catalytic triad (HIS51, ASP75
and SER135); sequences are numbered accordingly to the full constructs and shaded based on sequence similarities (black for
identical, dark gray for strongly similar and soft gray for weakly similar residues).
doi: 10.1371/journal.pone.0072402.g002
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DENV structures, but not among WNV, indicating that this
conformation may be stabilized by ligand binding.
Homology Modeling.  Our strategy was initially to build a
robust model of the NS3PRO domain and next to add the
NS2BCF, the ligand and the linker pieces to achieve the active
conformation of the NS2BCF-Gly-NS3PRO model, which was later
used in the MD simulations. For that purpose, we first built two
preliminary NS3PRO models based exclusively either on the
DENV or on the WNV structures. Besides belonging to different
species, the main difference observed was the absence
(DENV) or the presence (WNV) of ligands. Among the five
models generated by MODELLER from each template set,
those with the lowest energies were analyzed. Overall, the
models did not differ much at the protein core, whereas, given
the divergence on the amount of information between
templates, N- and C-terminus were quite distinct. For the model
based on the DENV structures, the C-terminal end was
arranged more concisely in an alpha-helix shape, which was
not observed in the model based on WNV NS3PRO. On the
other hand, the WNV-based model had its N-terminal end
projected into a beta strand that contributes to one of the beta-
sheets found in the protein (data not shown).
The superposition of these two 3D models based exclusively
on the WNV or DENV NS3PRO provided different features that
were considered to build a third NS3PRO model. In this last
model, the protein core was modeled as the conserved
consensus of all template structures, while the N-terminal
region came from WNV proteases and the C-terminal end from
the DENV proteases. After visually comparing the structures of
the three models, we finally retained the third one, which
contained less disordered coils and loops, to be used in the
next building steps to obtain the final NS2BCF-Gly-NS3PRO
model.
After being verified by PROCHECK, the complete NS2BCF-
Gly-NS3PRO model was found to be of acceptable accuracy
(over 96% residues in allowed regions) and was chosen as
definitive to carry on further studies (File S1). Figure 3B shows
the structural alignment of the finished homology model with
the newly available ligand-bound DENV structure (PDB id:
3U1I) [36]. The alignment has a Cα atom RMSD of 0.9 Å for
195 atoms, which gives consistency to our built model.
Additionally, as pointed by Knehans et al. [24], the oxyanion
hole was also present in our model (Figure 3B, boxed detail),
even though we did not used restraints during homology
modeling. Those features, together with our model
completeness, including both inhibitor and cofactor in the active
conformations, as well as the gap-filling loop grafts directed by
Table 2. Homology modeling templates and their catalytic
triad main-chain atom RMSD to the reference protein
2FOM, based on the 126 conserved residues from the
NS3PRO domain.
PDB id RMSD (Å)
 Protein HIS51 ASP75 SER135
2VBC 1.3984 0.448 0.796 0.815
2WHX 1.4121 0.503 0.851 0.764
3L6P 1.3000 0.263 0.323 0.468
2FP7 1.3620 0.412 0.833 0.717
2IJO 1.3330 0.504 0.996 0.784
3E90 1.2913 0.543 0.846 0.696
Figure 3.  Structural alignments between (A) core region from all templates used in homology modeling, and (B) obtained
model and recently available ligand bound DENV NS3PRO structure (PDB id: 3U1I).   [36]. In (A), residues were colored based
on their Qres factor, obtained after a STAMP structure alignment performed with the VMD Multiseq plugin [68]. Color ranges from
dark blue (highly conserved positions) to red (not conserved at all). In (B), crystallographic structure was colored with gray (NS3PRO)
and red (NS2BCF); homology model was colored in lighter shades – white (NS3PRO) and pink (NS2BCF). In addition to the highly
conserved active site residues position, the oxyanion hole was also preserved in this model (boxed detail).
doi: 10.1371/journal.pone.0072402.g003
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structural evidences found both in DENV and in WNV
structures, made our NS2BCF-Gly-NS3PRO model a good
starting point for MD simulations and the structure-based virtual
screening campaign.
Protein model overall stability and flexibility
Molecular dynamics.  The timeline analysis of the
secondary structure pieces during the 30 ns of MD simulations
(Figure 4) showed that protein domains were stable during the
trajectory, especially concerning extended conformations (in
yellow). Turns and coils (teal and white, respectively), including
the polyglycine linker (NS2B residues 95 to 104), constantly
alternated between those two types of conformations.
After the MD simulation run, both the ligand and the cofactor
remained closely bound to the NS3PRO domain (Figure S2).
Each frame collected from the trajectory file was then aligned
to the first one based on their heavy atoms. RMSD analysis
shows a 4-stages curve, with an increasing value in the first 2
ns, after which the model stabilizes for the next 5 ns, followed
by a new increase and final stabilization after 15 ns (Figure 5A,
NS3PRO F). However, this stabilization is achieved soon after
equilibration (before 1 ns of simulation), and with much lower
RMSD values (average RMSD of 2.2 versus 5.97 Å), when we
analyze the protein core alone (residues 20 to 168, Figure 5A,
NS3PRO C). As the secondary structure modifications during MD
simulations could not account for such a high deviation when
analyzing the whole model, we supposed that this was rather
due to domain flexibility, which in turn could regulate the
access to the binding site.
As it would be impossible to explore each frame separately
in vHTS studies, we decided to use a two-dimensional plot
clustering technique capable of investigating the structural
relatedness of different parts of a MD trajectory (Figure 5B). By
doing so, 4 distinct conformational families were detected when
analyzing the whole sample, but only two (and with a high
degree of relationship) could be detected while analyzing the
protein core alone. By choosing the most conserved spots in
the two-dimensional RMSD plot, representatives of each
conformational family (snapshots corresponding to frames 200,
400, 600 and 800, Figure 5C) were selected for conformational
analysis of the binding site. As the last cluster (frames 800 to
1000) contained several conformations related to the previous
one (frames 400 to 800), we picked up the frame 800, instead
of 900, as an averaged representative of the last family of
conformations.
Principal component analysis (PCA).  To verify which
motions could account for RMSD variations, we finally
performed a principal component analysis (PCA) from the MD
trajectory. Results for the first 5 eigenvectors confirm that the
greatest motions were contained within the first two
eigenvectors and they indeed came from the NS3PRO C-
terminal end (Figure 6). This region has been described as
highly flexible, as noticed by differences in the two
crystallographic structures for the full (both proteolytic and
helicase domains) NS3 construct [34,51,52]. However, this fact
does not exclude the possible existence of small but significant
motions that may be important for binding site plasticity (Figure
6B). To investigate further this question, we also performed 2D
ligand-receptor interaction plots.
Protein binding site and binding modes flexibilities
Binding pocket detection and evolution.  The DENV
protease has a very shallow pocket [33,53], a fact that led us to
employ the METAPOCKET servers. This server utilizes several
redundant already validated geometric algorithms to search for
proteins cavities. Thus, where one algorithm may fail, another
one can correct the results, providing accurate topological
information. This chosen pocket detection strategy showed to
be in accordance with experimental data, with almost 70%
(15/22, Table 3) accuracy. Both S1 and S4 sub-pockets were
fully detected, with less favorable results for sub-pockets S2
and S3 with 37.5 and 33.3% accuracy, respectively. It is
noteworthy to say that this method was capable of detecting
several residues not present in the experimental data. Those
residues may constitute useful sub-pockets for designing new
competitive molecules.
Following detection, the protease pocket coordinates (Figure
7A) were subjected to the MD pocket algorithm to be monitored
for volume changes. As in many proteases [54–57], the pocket
volume presented a ‘breathing’ behavior, adopting a sinusoidal
curve when plotted against time (Figure 7B). This suggested
that, even if the protein core remained stable during the same
simulation, the binding site accessibility seemed to change,
probably due to allosteric modulation provided by the more
flexible domains.
Protein/ligand interactions evolution.  Ligplots of the
protein/ligand binding modes (Figure 8) showed changes in
both the protein sub-pockets conformation and in ligand
interactions, indicating that the binding site is definitely not
static and that this plasticity could be explored for competitive
structure based drug design.
Noteworthy was the fact that the residues from the S2 sub-
pocket were represented only by THR83 in the conformations
2-4, but this could not be depicted in the conformation 1. In this
case, the protein relaxation promoted by the MD simulation
may have exposed this residue so it could be detected by this
method. The residues from the S3 pocket (MET84, LYS85 and
ILE86) showed the same pattern, all absent in conformer 1 but
with variable incidence in the other conformations. As for
residue interactions, some were more conserved than others.
In all conformations, residues GLY133 and GLY153 were involved
with hydrogen bonds between their main chain atoms and the
C-terminal oxygen from P1 and the backbone oxygen from P2,
respectively. On the other hand, π-interactions seemed to need
a more constrained conformation, as this was observed only
with the aromatic residues TYR161 (with both P1 and P3) and
HIS51 (with P2) of the first conformation. Hydrogen bonds
coming from SER135, GLY151 and THR134 were less conserved,
but also related to the C-terminal oxygen from P1. Interactions
between P3 and S3 were observed only in conformations 2 and
4; side-chain interactions from P1 were observed only in
conformation 1 and 4.
To investigate further the plasticity of the DENV NS2B
CFNS3PRO binding site and the possible consequences on ligand
binding, we analyzed the protein/ligand interactions during the
Dengue Virus NS3PRO Active Site Flexibility
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whole MD trajectory. For that purpose, we calculated the pair
interaction energies between the ligand NDL and the protein
(Figure 9A, black line), the ligand and surrounding water
(Figure 9A, gray line) and for the ligand with each protein
residue (Figure 9B). Contact points between ligand and protein
could be mapped by plotting the average total energy (potential
plus kinetic) of each residue. Similar to results obtained from
the binding plots, the main residues involved in the interactions
with the ligand were from the sub-pockets S3 (residues MET84,
LYS85 and ILE86), and all the residues from S1 and S4. The
greatest interaction averages came from ASP129, followed by
THR134 and SER135 from S1. However, the evaluation of pair
interaction forces was more sensitive for detecting residues
from the sub-pocket S2, as it was able to recognize residues
Figure 4.  Secondary structure timeline analysis as computed by the timeline plugin contained in VMD.  In the graphic, the β-
sheet components turn (T) and extended conformation (E) are represented in teal and yellow respectively; isolated bridges are in
dark yellow; degrees of helix are in pink (α-helix), blue (3-10 helix) and red (π-helix); random coils are in white.
doi: 10.1371/journal.pone.0072402.g004
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ASP75, LYS73 and VAL72, none of them found within any
conformation inspected through the ligand-binding plots.
When analyzing the ligand/protein and the ligand/water
interactions together (Figure 9A), we could see that while the
energy of the former increases (thus, diminishing ligand-protein
attraction), the latter seems to decrease proportionally
(enhancing the ligand-water attraction). This is normally
expected, as during MD simulations, the protein-ligand
complex becomes more relaxed, allowing water to interact with
the residues from the binding site. This results in decreased
interactions between ligand and protein. It is interesting to note
that, despite the attraction between ligand and protein being
diminished at the beginning of the simulation, the complex
achieves stabilization after 10 ns. In fact, one can say that
during the last 5 ns of simulation, the protein-ligand interaction
increases again, approaching the initial state.
Discussion
One of the limitations in using crystallographic structures in
structure-based drug design is the fact that those structures are
often related to a particular energy minima state, which is a
single conformation among many possible ones. Although this
does not represent a significant problem, it may undermine
virtual high-throughput campaigns. To circumvent this issue,
one may use a range of strategies for simulating protein
flexibility, among which we can highlight the ensemble docking
with structures derived from molecular dynamics simulations
[38,40,41].
In the last few years, several DENV NS3PRO automatic
docking studies were published based on homology models
[23–26,58–60]. In our work, besides investigating protein
flexibility, we were careful to build our DENV NS3PRO model in
the predicted active conformational state (including the
oxyanion hole), a concern also present in the study by
Figure 5.  Single- and two-dimensional RMSD plots from the MD simulation trajectory, and their representative
conformers.  In (A), RMSD values from the whole construct (NS3PRO F, black line) were compared with RMSD values from the
protein core only (NS3PRO C, gray line). In (B), a two-dimensional RMSD plot was utilized to provide information about
conformational families during trajectory. Color ranges from black (as out of the cut-out distance) to white (as in identical structures),
with intermediate values depicted in the color scale. White stars mark the representative frames. (C) Snapshots of representative
conformations of each family extracted from the clustered (two-dimensional) RMSD analysis (NS2BCF and linker in red, NS3PRO in
gray, active site residues in green and NDL in orange).
doi: 10.1371/journal.pone.0072402.g005
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Knehans et al. [24]. However, most of the other studies were
based either on the retracted apoenzyme structure [26,59], or
in the open holoenzyme conformation [23,25,58] and were
based on a rigid protein system with a single conformation.
The first homology model for the DENV NS2B/NS3 protease
was done by Brinkworth et al. in 1999 [61]. However, as it was
built based on the more distantly related hepatitis C virus NS3/
NS4A protease (PDB id 1JXP [62]), several structural
differences (Cα RMSD of 11 Å) were observed when
comparing it to the recently resolved DENV-3 NS2B/NS3
protease (PDB id 3U1I [35]). Also, this work did not take into
account the ligand-binding induced fit mechanism, as it was yet
to be proposed [33,63], and thus, ligand was absent from their
model. Later, in 2007, Kee et al. [64] used this same model for
automatic docking studies. In 2004 and 2005, respectively,
Niyomrattanakit et al. [65] and Chanprapaph et al. [60] built
homology models based on the now retracted apo DENV
NS3PRO structure. Similarly, Ganesh et al., in 2005 [59], and
Tomlinson et al., in 2009 [26], used homology models based on
the retracted structure for automatic docking studies. For
studying the importance of domain motion between the NS3PRO
and NS3HEL domains through MD simulations (1 ns), Rosales-
León et al., in 2007 [66], built a full DENV NS3 model, but also
based on this retracted structure. In 2010, two groups [29,67]
independently published a similar approach for building active
conformational models, where the cofactor and the ligand were
extracted from the WNV NS2BCF/NS3PRO structure (PDB id
2FP7) and fused to the DENV NS3PRO. However, the oxyanion
hole is not in the active conformation in the work by Wichapong
and colleagues [67], and could not be accessed in the work by
Frecer and Miertus [29] for further comparisons. Also, neither
models presented linker regions nor grafted loops.
Regarding protein flexibility, Ekonomiuk et al. [31] also
postulated that it would be important to access new
conformations for vHTS in the case of the WNV protease.
However, instead of performing a long MD simulation, they
Table 3. Pocket residues as detected by METAPOCKET
compared to those found experimentally.
Sub-pocket NS2B NS3
 Detected Expected Detected Expected
S1 - - D129 D129
 - - F130 F130
 - - K131 K131
 - - P132 P132
 - - G133 G133
 - - T134 T134
 - - S135 S135
 - - Y150 Y150
 - - Y161 Y161
S2 - D80 - V72
 D81 D81 - K73
 - G82 - K74
 T83 T83 D75 D75
S3 M84 M84 - -
 - K85 - -
 - I86 - -
S4 - - V154 V154
 - - V155 V155
N/A* - - Q35 -
 - - V36 -
 - - W50 -
 - - H51 -
 - - G151 -
 - - N152 -
 - - G153 -
Detected pockets were identified by METAPOCKET, as described in Methods. *
Detected residues which may be important to ligand binding, but were not
previously reported in literature.
Figure 6.  Individual residue mobility in principal component analysis.  (A) The greatest eigenvector represents NS3PRO C-
terminal domain shifting, and the second eigenvector represents NS2BCF C-terminal and glycine linker shifts. (B) Normal mode
visualization from the first eigenvector, also revealing small motions that may be important to binding site plasticity.
doi: 10.1371/journal.pone.0072402.g006
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Figure 7.  Pocket detection and evolution during MD simulation trajectory.  Active site pocket (A) was identified by
METAPOCKET and later monitored for changes in volume (B) by MD Pocket. In (A), DENV NS3PRO is represented in gray; NS2BCF
and the glycine linker are in red. Active site residues are represented by green sticks, and the detected pocket is shown in a cyan
surface. The pocket opposed to the active site, usually found in ligand bound structures (35) is depicted in a brown surface, merely
for illustration. In (B), the red line is a smoothed curve of the black line, intended to clarify the breathing behavior of the active site.
doi: 10.1371/journal.pone.0072402.g007
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preferred a short run (1 ns) to look for a conformation able to
better accommodate a benzene ring later used for fragment
docking. Figure 5A shows the importance of performing a
longer simulation to our purposes: even if a protein seems
stable during shorter trajectories, they can surpass greater
conformational changes after longer simulation times, revealing
Figure 8.  Binding mode fluctuations during the MD simulation.  Both ligand and binding site plasticity contributes to changes in
the binding mode between the ligand and protein. The solvent accessible surface of an interacting residue or atom is represented by
a blue halo around it. The diameter of the circle is proportional to the solvent accessible surface. Pink circles indicate residues
involved in hydrogen-bond, polar or charged interactions; green circles indicates residues involved in van der Waals interactions; π-
interactions are represented by orange lines; green arrows indicate hydrogen-bonds interactions with amino acid main chains; blue
arrows indicate side chain hydrogen-bond interactions. Arrowhead directs towards the electron donor.
doi: 10.1371/journal.pone.0072402.g008
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important motions that otherwise would not be detectable.
These motions can be related to important conformational
states found during protein equilibrium, which in turn could be
subjected to vHTS. When comparing the one- and two-
dimensional RMSD graphs, we can observe that the variations
in the former are related to conformational changes in the
latter, which are maintained in a clustered family. This means
that conformational changes observed in the one-dimensional
RMSD plot last for some time, which is extremely desirable for
finding new inhibitors that may bind to this protein state.
Despite presenting higher conservation during the trajectory,
the binding site also presents considerable plasticity that may
be important in structure-based drug discovery. In the work by
Ekonomiuk et al. [31], backbone changes as low as 0.8 Å
between the crystallographic structure and their model
extracted from MD simulations were enough to better
accommodate three different fragments used in vHTS. In our
case, the average binding site heavy atoms deviation was
approximately 2 Å, reflecting changes both in pocket volume
(Figure 7B) and in ligand binding modes (Figure 8).
In an already mentioned work, Wichapong et al. [67]
performed 10 ns of MD simulations to examine ligand-protein
interactions in three different models. Irrespective of the
differences between this work and that of Wichapong and
colleagues’ (for example: the inhibitor was covalently bound to
SER135, the absence of the linker region and grafted loops, and
the position of the oxyanion hole), our analysis seems to be in
accordance with theirs. However, as they did not perform time-
wise analysis related to different points in the trajectory,
changes in the binding modes through the simulation could not
be evaluated.
Despite the fact that almost every binding pocket residue
found in the literature was also detected in our study, binding
modes were sometimes quite distinct. With the recent
publication of the ligand-bound structure of the DENV-3 NS3
protease [36], using the same inhibitor used in our study, we
were able to compare the protease sub-pockets. While in the
crystallographic data GLY151 interacts with the P2 residue from
the inhibitor, in our study it interacts promptly with the P1
residue. Other changes include GLY153, part of the S3 sub-
pocket in the crystallographic structure, but conserved in S2 in
all conformations from our model; and the residue TYR161,
which was capable of making π-interactions with both P1 and
P3 residues in our studies, while it is described as a S1 sub-
pocket residue in the crystallographic structure. Also, LYS85
from the cofactor NS2B was able to produce a charge-charge
interaction with the P3 LYS from the inhibitor, a fact not
observed in the work from Noble et al. [36]. Altogether, those
changes in binding mode, either between our models and the
crystallographic structure or among different conformations
extracted from our MD simulations, indicate that the binding
site indeed presents significant flexibility that could be explored
in structure-based drug design.
Conclusions
This article describes the analysis of the Dengue virus NS3
protease flexibility through molecular dynamics simulations, as
a part of an ensemble docking campaign for identifying
potential new leads for drug design. As a result, we were able
to clearly distinguish four different conformational states, which
are being used in a subsequent virtual high-throughput
ensemble docking campaign. By doing so, we hope to discover
new promising molecules with therapeutic potential to treat this
life-threatening disease.
Supporting Information
Figure S1.  The binding site of each representative
conformation identified by our clustering strategy. The
NDL inhibitor is displayed as a stick model (C, O and N atoms
in white, red, and blue, respectively). Residues participating in
the binding site are displayed both as thin sticks and as
transparent surfaces colored accordingly to the residue name.
The plasticity of the binding site environment and in the binding
Figure 9.  Total pair interaction energies (potential plus kinetic).  (A) Pair interactions from the ligand NDL versus protein (black
line), and NDL versus water (gray line). (B) Average total energy of pair interactions from the ligand and each protein residue,
allowing for contact points mapping.
doi: 10.1371/journal.pone.0072402.g009
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modes is evidenced by the differences observed during the
molecular dynamics simulations.
(TIF)
Figure S2.  Snapshot from the last frame of the 30ns
trajectory, showing that both the inhibitor and the cofactor
remain closely bound to the NS3 protease. The NS2BCF is
maintained in the “closed” conformation. NS3PRO is depicted in
gray, NS2BCF (and linker) in red. Active site side-chains are
represented as green sticks, and the NDL inhibitor in orange.
(TIF)
File S1.  PDB file of the final model with all its
components: NS3PRO, NS2BCF, glycine linker and NDL
inhibitor. For displaying it in a molecular viewing program
(such as VMD), please copy the content of the. doc file, paste it
into a new document in a simple text editor (MS Windows
notepad, for instance), and save it with a. pdb file extension.
(DOC)
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